Zobrazeno 1 - 10
of 57
pro vyhledávání: '"Jan Frisell"'
Autor:
Jana de Boniface, Jan Frisell, Thorsten Kühn, Ingrid Wiklander-Bråkenhielm, Karin Dembrower, Per Nyman, Athanasios Zouzos, Bernd Gerber, Toralf Reimer, Steffi Hartmann
Publikováno v:
Breast Cancer Research and Treatment. 193:589-595
Purpose In clinically node-positive breast cancer patients receiving neoadjuvant systemic therapy (NST), nodal metastases can be initially marked and then removed during surgical axillary staging. Marking methods vary significantly in terms of feasib
Publikováno v:
The British journal of surgery. 108(5)
Background This follow-up analysis of a Swedish prospective multicentre trial had the primary aim to determine invasive disease-free (IDFS), breast cancer-specific (BCSS) and overall survival (OS) rates, and their association with axillary staging re
Publikováno v:
Breast Cancer Research and Treatment. 171:359-369
The clinical significance of lymph node micrometastases and isolated tumor cells (ITCs) in breast cancer is still controversial. After a median follow-up of 52 months, a report from the Swedish Multicenter Cohort Study presented a worse cancer-specif
Autor:
Inkeri Schultz, Per Hall, Martin Halle, A-C Docherty Skogh, J. de Boniface, Å. Edsander Nord, Jan Frisell, H. Adam, Jessica Gahm
Publikováno v:
Cancer Research. 78:P4-13
PURPOSE Post-mastectomy reconstruction using the deep inferior epigastric perforator (DIEP) flap is increasingly performed in breast cancer patients. The procedure induces large tissue trauma and it has been hypothesized that the release of growth fa
Autor:
Sven Törnberg, Juni Palmgren, Camilla Cristando, Daniel Klevebring, Emma Ivansson, Jan Frisell, Jonas Bergh, Linda S. Lindström, Per Hall, Keith Humphreys, Gabriela Prochazka, Jingmei Li, Johan Hartman, Johan Lindberg, Nicholas P. Tobin, Kamila Czene, Johanna B. Holm, Henrik Grönberg, Mattias Rantalainen
Publikováno v:
Clinical Cancer Research. 23:2584-2592
Purpose: Interval breast cancer is of clinical interest, as it exhibits an aggressive phenotype and evades detection by screening mammography. A comprehensive picture of somatic changes that drive tumors to become symptomatic in the screening interva
Autor:
Fuat Celebioglu, L. Zetterlund, Jan Frisell, Athanasios Zouzos, Thomas Hatschek, Rimma Axelsson, Jana de Boniface
Publikováno v:
Breast Cancer Research and Treatment
Purpose Patients with clinically node-positive breast cancer planned for neoadjuvant systemic therapy (NAST) may draw advantages from the nodal downstaging effect and reduce the extent of axillary surgery with sentinel lymph node biopsy (SLNB) perfor
Publikováno v:
Breast Cancer Research and Treatment
Purpose The timing of sentinel lymph node biopsy (SLNB) in the context of neoadjuvant systemic therapy (NAST) in breast cancer is still controversial. SLNB before NAST has been evaluated in few single-institution studies in which axillary lymph node
Publikováno v:
British Journal of Surgery. 104:238-247
Background The omission of axillary lymph node dissection (ALND) in patients with breast cancer with a negative finding on sentinel node biopsy (SNB) has reduced arm morbidity substantially. Early follow-up reports have shown the rate of axillary rec
Publikováno v:
Breast Cancer Research and Treatment
Purpose: Increasing evidence suggests that completion axillary lymph node dissection (ALND) may be omitted in breast cancer patients with limited axillary nodal metastases. However, the representativeness of trial participants for the original clinic
Publikováno v:
European Journal of Cancer. 138:S22